Abstract P037: A Phase 1/2 Dose Escalation and Expansion Study of OP-1250 in Adults with Advanced And/or Metastatic Hormone Receptor-Positive (HR+), HER2-negative (HER2−) Breast Cancer
Molecular Cancer Therapeutics(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined